Showing 34,301 - 34,320 results of 67,825 for search '(( 50 ((n decrease) OR (mean decrease)) ) OR ( 5 ((a decrease) OR (we decrease)) ))', query time: 1.26s Refine Results
  1. 34301

    Data Sheet 1_Identification of a multiple DAMP scavenger mimicking the DAMP-binding site of TLR4 to ameliorate lethal sepsis.pdf by Takuya Murao (114383)

    Published 2025
    “…OP18 was developed by identifying a 15-amino acid (aa) binding site within the extracellular domain of Toll-like receptor 4 (TLR4) shared by eCIRP, HMGB1, and histone H3, then extending it with an α<sub>v</sub>β<sub>3</sub>-integrin binding RGD (Arg-Gly-Asp) motif, resulting in an 18-aa peptide. …”
  2. 34302
  3. 34303
  4. 34304
  5. 34305

    Correlation between the RS rate and temperature. by Yueqin Chen (5811368)

    Published 2025
    “…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
  6. 34306

    Schematic diagram of experimental area selection. by Yueqin Chen (5811368)

    Published 2025
    “…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
  7. 34307

    Influence of N-addition on soil RH. by Yueqin Chen (5811368)

    Published 2025
    “…The experimental results showed that low nitrogen addition rate (5 g·m<sup>-2</sup>·yr<sup>-1</sup>) increased soil respiration rate by about 11% in summer, but decreased it by about 6% in winter, with a range of 5% to 20%. …”
  8. 34308

    Image_1_Biosynthesis of Silver Nanoparticles by Marine Actinobacterium Nocardiopsis dassonvillei and Exploring Their Therapeutic Potentials.jpg by Maha A. Khalil (11454121)

    Published 2022
    “…In vitro studies using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay revealed a concentration-dependent decrease in cell viability when CaCo2 cells were exposed to Bio-AgNPs. …”
  9. 34309

    DataSheet1_Voluntary wheel running reduces tumor growth and increases capillarity in the heart during doxorubicin chemotherapy in a murine model of breast cancer.pdf by Tytti-Maria Uurasmaa (13267149)

    Published 2024
    “…Two weeks later, doxorubicin treatment was started via intraperitoneal administration (5 mg/kg weekly for 3 weeks). Organs were harvested a day after the last dose.…”
  10. 34310

    Image4_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  11. 34311

    Image6_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  12. 34312

    Image3_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  13. 34313

    Table2_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.DOCX by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  14. 34314

    Image1_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  15. 34315

    Table4_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  16. 34316

    Image2_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  17. 34317

    Image7_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.JPEG by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  18. 34318

    Table3_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  19. 34319

    Table1_The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis.docx by Paolo Comeglio (14195007)

    Published 2024
    “…Selvigaltin (previously known as GB1211) is a novel orally active galectin-3 small molecule inhibitor that has high affinity for galectin-3 (human K<sub>D</sub> = 25 nM; rabbit K<sub>D</sub> = 12 nM) and high oral bioavailability in rabbits and man. …”
  20. 34320